Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-19-030586

President and CEO acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Chan Phillip P. President and CEO 2019-06-07 Option exercise +20,000 $4.33 $86,500 515,582 D
Derivatives
Chan Phillip P. President and CEO 2019-06-07 Option exercise · Stock Option (right to buy) −20,000 0 D
Loading xslF345X03/tv523396_4.xml…